Patents by Inventor Wenjiang Huang

Wenjiang Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240298612
    Abstract: A method and a device for a predicting desert locust are provided. The method includes: acquiring environment factor data of a target area, where the environment factor data includes total precipitation data, soil temperature data, soil water data, and vegetation index data; extracting fluctuation features corresponding to the environment factor data through wavelet transform, where the fluctuation features include a precipitation fluctuation feature corresponding to the total precipitation data, a soil temperature fluctuation feature corresponding to the soil temperature data, a soil water fluctuation feature corresponding to the soil water data, and a vegetation fluctuation feature corresponding to the vegetation index data; and predicting time when the desert locust presents in the target area based on the fluctuation features.
    Type: Application
    Filed: July 14, 2023
    Publication date: September 12, 2024
    Applicant: AEROSPACE INFORMATION RESEARCH INSTITUTE, CHINESE ACADEMY OF SCIENCES
    Inventors: Yingying DONG, Yuzhen ZOU, Xueling LI, Linyi LIU, Wenjiang HUANG, Xing ZHAO
  • Publication number: 20190211003
    Abstract: The invention discloses 20,23-modified novel derivatives of 16-membered demycarosyltylonolide antibiotics, which are useful against bacterial and mycoplasmic pathogens in humans and animals. Also claimed are pharmaceutical compositions of such derivatives and their use in treating bacterial and mycoplasmic infections in humans and animals.
    Type: Application
    Filed: March 17, 2019
    Publication date: July 11, 2019
    Applicant: VICTOR PHARMA CO., LTD. ZHENJIANG
    Inventors: Haiqing YUAN, Wenjiang HUANG
  • Patent number: 10287275
    Abstract: The invention discloses 20,23-modified novel derivatives of 16-membered demycarosyltylonolide antibiotics, which are useful against bacterial and mycoplasmic pathogens in humans and animals. Also claimed are pharmaceutical compositions of such derivatives and their use in treating bacterial and mycoplasmic infections in humans and animals.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: May 14, 2019
    Assignee: VICTOR PHARMA CO., LTD. ZHENJIANG
    Inventors: Haiqing Yuan, Wenjiang Huang
  • Publication number: 20180148434
    Abstract: The invention discloses 20,23-modified novel derivatives of 16-membered demycarosyltylonolide antibiotics, which are useful against bacterial and mycoplasmic pathogens in humans and animals. Also claimed are pharmaceutical compositions of such derivatives and their use in treating bacterial and mycoplasmic infections in humans and animals.
    Type: Application
    Filed: July 2, 2015
    Publication date: May 31, 2018
    Inventors: Haiqing Yuan, Wenjiang Huang